An international consensus conference on pediatric sepsis (2005) established definitions for various terms, including systemic inflammatory response syndrome (SIRS), infection, sepsis, severe sepsis, and septic shock.
It was found that severe sepsis and septic shock are major contributors to child mortality globally, accounting for a significant portion of the 4 million deaths from infectious diseases in children under five.
The SPROUT Study, conducted across 26 countries, reported an 8.2% prevalence of severe sepsis among 6,925 children in pediatric intensive care units – with variations between developed and developing countries. A systematic analysis by Fleischmann-Struzek et al. estimated 48 cases of sepsis and 22 cases of severe sepsis per 100,000 person-years, with mortality rates ranging from 1-5% for sepsis and 9-20% for severe sepsis. Common risk factors included central venous devices, organ transplantation, and underlying chronic diseases.
Mortality rates from pediatric sepsis have decreased over the past two decades, but significant disparities exist between developed and developing countries. Children with medical comorbidities face higher in-hospital mortality rates, with younger age, organ dysfunction, and septic shock also contributing to increased mortality. Early deaths often result from refractory shock, while late deaths are linked to multiple organ dysfunction.
Clinical manifestations of sepsis in neonates can be nonspecific, requiring a high index of suspicion. Early recognition through sepsis screens, such as the 'Best Practice Alert' and the Pediatric Septic Shock Collaborative's screening tools, is crucial. Machine learning and artificial intelligence have shown promise in predicting severe sepsis earlier than traditional screening tools.
While biomarkers like CRP and procalcitonin aid in risk stratification, no single biomarker offers diagnostic and prognostic capabilities in pediatric sepsis. The 2020 Surviving Sepsis Campaign guidelines recommend systematic screening and protocol-based management. Timely initiation of antimicrobial therapy, appropriate fluid resuscitation, and vasoactive agents are key components of sepsis management.
In resource-limited settings, challenges include malnutrition, limited equipment, and disease-specific considerations. The Indian Academy of Pediatrics emphasizes a tailored approach in such settings. This suggests that interventions like oxygen therapy and fluid resuscitation can be performed even at primary and secondary health facilities.
Despite existing evidence, knowledge gaps persist, and future research should focus on global, multicenter studies to tailor interventions based on diverse patient populations and resource availability. Pediatric sepsis remains a significant global health challenge, necessitating early recognition, effective management, and ongoing research to improve outcomes.
Source: Kannikeswaran N, Mahajan P. Indian Pediatr. 2023 Dec;60(12):981-4.
Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.
Please login to comment on this article